Clinical trials
Terminated Lymphoma, Large B-Cell, Diffuse trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Antengene Corporation | 2 |
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| BeOne Medicines | 1 |
| BioNova Pharmaceuticals (Shanghai) LTD. | 1 |
| Fudan University | 1 |
| JHL Biotech, Inc. | 1 |
| MingSight Pharmaceuticals, Inc | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 12 |
| Lymphoma, Follicular | 5 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, B-Cell | 2 |
| Recurrence | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.